Mylan CEO Heather Bresch says the EpiPen price increase was necessary but the company will offer a $300 generic option Julie Mazziotta is the Senior Sports Editor at PEOPLE, covering everything ...
Heather Bresch, the former president and CEO of the drugmaker Mylan, worked directly with the CEO of Pfizer to keep prices of the company’s EpiPen product artificially high, according to new documents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback